The global high potency active pharmaceutical ingredient (HPAPI) market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The major factor driving the demand for the global high potency active pharmaceutical ingredients (HPAPI) market during the forecast period is the increasing demand for these drugs across the globe. The global HPAPI market is growing especially after the COVID-19 pandemic due to which governments focus on pharmaceutical raw materials like high potency active ingredients which drive the growth of the market.
Browse the full report description “Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Size, Share and Trends Analysis Report, By Type (Innovative HPAPI and Generic HPAPI), By Type of Synthesis (Synthetic HPAPI and Biotech HPAPI), By Application (Oncology, Glaucoma, Hormonal Disorder, and Others), Forecast (2022-2028)“at https://www.omrglobal.com/industry-reports/high-potency-active-pharmaceutical-ingredients-hpapi-market
Furthermore, targeted therapy is getting popular as compared to drugs or chemotherapy as it does not harm non-cancerous cells. Moreover, the growth of the market is also attributed to the increasing prevalence of cancer. According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Furthermore, there were 18.1 million new cases globally in 2018 which is anticipated to rise to 29.5 million by 2040.
In addition, investment by pharmaceutical companies in R&D activities for expanding the HPAPI manufacturing sites and developing potent drugs will boost the market growth. For instance, in September 2020, Merck announced $65.2 million for the expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, US. However, special containment facilities require significant investment, transporting, and managing HPAPI which is extremely dangerous and costly as well as toxic to the health of associates working in manufacturing centers. These are some factors that act as a restriction for the growth of the global HPAPI market.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- including BASF SE, Corden Pharma International GmbH, Cambrex Corp., CARBOGEN AMCIS AG, Dr. Reddy’s Laboratories Ltd., and Others.
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report Segment
By Type
By Type of Synthesis
By Application
Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/high-potency-active-pharmaceutical-ingredients-hpapi-market